Baku 13° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
18:54
Photo
Luncheon hosted in honor of First Lady Mehriban Aliyeva
Foreign policy18:48
Photo
3,322 evacuated from Iran to Azerbaijan so far
Domestic policy18:35
Photo
Azerbaijani universities pitch study options in Kazakhstan
Education and science18:14
Azerbaijan permits export of cherry saplings to Uzbekistan
AIC18:08
Photo
Video
President of Azerbaijan and Prime Minister of Georgia delivered press statements - UPDATED
Foreign policy18:05
5 Killed in fire following traffic collision in Afghanistan's Baghlan
Other countries17:56
Turkish, Iranian FMs discuss regional tensions by phone
Region17:37
Crocus City Hall attack accomplice commits suicide in Moscow detention center
Region17:23
Photo